Discovering Pathology Rationale and Token Allocation for Efficient Multimodal Pathology Reasoning

Multimodal pathological image understanding has garnered widespread interest due to its potential to improve diagnostic accuracy and enable personalized treatment through integrated visual and textual data. However, existing methods exhibit limited reasoning capabilities, which hamper their ability to handle complex diagnostic scenarios. Additionally, the enormous size of pathological images leads to severe computational burdens, further restricting their practical deployment. To address these limitations, we introduce a novel bilateral reinforcement learning framework comprising two synergistic branches. One reinforcement branch enhances the reasoning capability by enabling the model to learn task-specific decision processes, i.e., pathology rationales, directly from labels without explicit reasoning supervision. While the other branch dynamically allocates a tailored number of tokens to different images based on both their visual content and task context, thereby optimizing computational efficiency. We apply our method to various pathological tasks such as visual question answering, cancer subtyping, and lesion detection. Extensive experiments show an average +41.7 absolute performance improvement with 70.3% lower inference costs over the base models, achieving both reasoning accuracy and computational efficiency.

Robustness and sex differences in skin cancer detection: logistic regression vs CNNs

Deep learning has been reported to achieve high performances in the detection of skin cancer, yet many challenges regarding the reproducibility of results and biases remain. This study is a replication (different data, same analysis) of a study on Alzheimer's disease [28] which studied robustness of logistic regression (LR) and convolutional neural networks (CNN) across patient sexes. We explore sex bias in skin cancer detection, using the PAD-UFES-20 dataset with LR trained on handcrafted features reflecting dermatological guidelines (ABCDE and the 7-point checklist), and a pre-trained ResNet-50 model. We evaluate these models in alignment with [28]: across multiple training datasets with varied sex composition to determine their robustness. Our results show that both the LR and the CNN were robust to the sex distributions, but the results also revealed that the CNN had a significantly higher accuracy (ACC) and area under the receiver operating characteristics (AUROC) for male patients than for female patients. We hope these findings to contribute to the growing field of investigating potential bias in popular medical machine learning methods. The data and relevant scripts to reproduce our results can be found in our Github.

Lung Nodule-SSM: Self-Supervised Lung Nodule Detection and Classification in Thoracic CT Images

Lung cancer remains among the deadliest types of cancer in recent decades, and early lung nodule detection is crucial for improving patient outcomes. The limited availability of annotated medical imaging data remains a bottleneck in developing accurate computer-aided diagnosis (CAD) systems. Self-supervised learning can help leverage large amounts of unlabeled data to develop more robust CAD systems. With the recent advent of transformer-based architecture and their ability to generalize to unseen tasks, there has been an effort within the healthcare community to adapt them to various medical downstream tasks. Thus, we propose a novel "LungNodule-SSM" method, which utilizes selfsupervised learning with DINOv2 as a backbone to enhance lung nodule detection and classification without annotated data. Our methodology has two stages: firstly, the DINOv2 model is pre-trained on unlabeled CT scans to learn robust feature representations, then secondly, these features are fine-tuned using transformer-based architectures for lesionlevel detection and accurate lung nodule diagnosis. The proposed method has been evaluated on the challenging LUNA 16 dataset, consisting of 888 CT scans, and compared with SOTA methods. Our experimental results show the superiority of our proposed method with an accuracy of 98.37%, explaining its effectiveness in lung nodule detection. The source code, datasets, and pre-processed data can be accessed using the link:https://github.com/EMeRALDsNRPU/Lung-Nodule-SSM-Self-Supervised-Lung-Nodule-Detection-and-Classification/tree/main

Improving Oral Cancer Outcomes Through Machine Learning and Dimensionality Reduction

Oral cancer presents a formidable challenge in oncology, necessitating early diagnosis and accurate prognosis to enhance patient survival rates. Recent advancements in machine learning and data mining have revolutionized traditional diagnostic methodologies, providing sophisticated and automated tools for differentiating between benign and malignant oral lesions. This study presents a comprehensive review of cutting-edge data mining methodologies, including Neural Networks, K-Nearest Neighbors (KNN), Support Vector Machines (SVM), and ensemble learning techniques, specifically applied to the diagnosis and prognosis of oral cancer. Through a rigorous comparative analysis, our findings reveal that Neural Networks surpass other models, achieving an impressive classification accuracy of 93,6 % in predicting oral cancer. Furthermore, we underscore the potential benefits of integrating feature selection and dimensionality reduction techniques to enhance model performance. These insights underscore the significant promise of advanced data mining techniques in bolstering early detection, optimizing treatment strategies, and ultimately improving patient outcomes in the realm of oral oncology.

Deep Learning Enabled Segmentation, Classification and Risk Assessment of Cervical Cancer

Cervical cancer, the fourth leading cause of cancer in women globally, requires early detection through Pap smear tests to identify precancerous changes and prevent disease progression. In this study, we performed a focused analysis by segmenting the cellular boundaries and drawing bounding boxes to isolate the cancer cells. A novel Deep Learning (DL) architecture, the ``Multi-Resolution Fusion Deep Convolutional Network", was proposed to effectively handle images with varying resolutions and aspect ratios, with its efficacy showcased using the SIPaKMeD dataset. The performance of this DL model was observed to be similar to the state-of-the-art models, with accuracy variations of a mere 2\% to 3\%, achieved using just 1.7 million learnable parameters, which is approximately 85 times less than the VGG-19 model. Furthermore, we introduced a multi-task learning technique that simultaneously performs segmentation and classification tasks and begets an Intersection over Union score of 0.83 and a classification accuracy of 90\%. The final stage of the workflow employs a probabilistic approach for risk assessment, extracting feature vectors to predict the likelihood of normal cells progressing to malignant states, which can be utilized for the prognosis of cervical cancer.

Automated Detection of Clinical Entities in Lung and Breast Cancer Reports Using NLP Techniques

Research projects, including those focused on cancer, rely on the manual extraction of information from clinical reports. This process is time-consuming and prone to errors, limiting the efficiency of data-driven approaches in healthcare. To address these challenges, Natural Language Processing (NLP) offers an alternative for automating the extraction of relevant data from electronic health records (EHRs). In this study, we focus on lung and breast cancer due to their high incidence and the significant impact they have on public health. Early detection and effective data management in both types of cancer are crucial for improving patient outcomes. To enhance the accuracy and efficiency of data extraction, we utilized GMV's NLP tool uQuery, which excels at identifying relevant entities in clinical texts and converting them into standardized formats such as SNOMED and OMOP. uQuery not only detects and classifies entities but also associates them with contextual information, including negated entities, temporal aspects, and patient-related details. In this work, we explore the use of NLP techniques, specifically Named Entity Recognition (NER), to automatically identify and extract key clinical information from EHRs related to these two cancers. A dataset from Health Research Institute Hospital La Fe (IIS La Fe), comprising 200 annotated breast cancer and 400 lung cancer reports, was used, with eight clinical entities manually labeled using the Doccano platform. To perform NER, we fine-tuned the bsc-bio-ehr-en3 model, a RoBERTa-based biomedical linguistic model pre-trained in Spanish. Fine-tuning was performed using the Transformers architecture, enabling accurate recognition of clinical entities in these cancer types. Our results demonstrate strong overall performance, particularly in identifying entities like MET and PAT, although challenges remain with less frequent entities like EVOL.

A Narrative Review on Large AI Models in Lung Cancer Screening, Diagnosis, and Treatment Planning

Lung cancer remains one of the most prevalent and fatal diseases worldwide, demanding accurate and timely diagnosis and treatment. Recent advancements in large AI models have significantly enhanced medical image understanding and clinical decision-making. This review systematically surveys the state-of-the-art in applying large AI models to lung cancer screening, diagnosis, prognosis, and treatment. We categorize existing models into modality-specific encoders, encoder-decoder frameworks, and joint encoder architectures, highlighting key examples such as CLIP, BLIP, Flamingo, BioViL-T, and GLoRIA. We further examine their performance in multimodal learning tasks using benchmark datasets like LIDC-IDRI, NLST, and MIMIC-CXR. Applications span pulmonary nodule detection, gene mutation prediction, multi-omics integration, and personalized treatment planning, with emerging evidence of clinical deployment and validation. Finally, we discuss current limitations in generalizability, interpretability, and regulatory compliance, proposing future directions for building scalable, explainable, and clinically integrated AI systems. Our review underscores the transformative potential of large AI models to personalize and optimize lung cancer care.

Anomaly Detection and Improvement of Clusters using Enhanced K-Means Algorithm

This paper introduces a unified approach to cluster refinement and anomaly detection in datasets. We propose a novel algorithm that iteratively reduces the intra-cluster variance of N clusters until a global minimum is reached, yielding tighter clusters than the standard k-means algorithm. We evaluate the method using intrinsic measures for unsupervised learning, including the silhouette coefficient, Calinski-Harabasz index, and Davies-Bouldin index, and extend it to anomaly detection by identifying points whose assignment causes a significant variance increase. External validation on synthetic data and the UCI Breast Cancer and UCI Wine Quality datasets employs the Jaccard similarity score, V-measure, and F1 score. Results show variance reductions of 18.7% and 88.1% on the synthetic and Wine Quality datasets, respectively, along with accuracy and F1 score improvements of 22.5% and 20.8% on the Wine Quality dataset.

Semi-Automated Quality Assurance in Digital Pathology: Tile Classification Approach

Quality assurance is a critical but underexplored area in digital pathology, where even minor artifacts can have significant effects. Artifacts have been shown to negatively impact the performance of AI diagnostic models. In current practice, trained staff manually review digitized images prior to release of these slides to pathologists which are then used to render a diagnosis. Conventional image processing approaches, provide a foundation for detecting artifacts on digital pathology slides. However, current tools do not leverage deep learning, which has the potential to improve detection accuracy and scalability. Despite these advancements, methods for quality assurance in digital pathology remain limited, presenting a gap for innovation. We propose an AI algorithm designed to screen digital pathology slides by analyzing tiles and categorizing them into one of 10 predefined artifact types or as background. This algorithm identifies and localizes artifacts, creating a map that highlights regions of interest. By directing human operators to specific tiles affected by artifacts, the algorithm minimizes the time and effort required to manually review entire slides for quality issues. From internal archives and The Cancer Genome Atlas, 133 whole slide images were selected and 10 artifacts were annotated using an internally developed software ZAPP (Mayo Clinic, Jacksonville, FL). Ablation study of multiple models at different tile sizes and magnification was performed. InceptionResNet was selected. Single artifact models were trained and tested, followed by a limited multiple instance model with artifacts that performed well together (chatter, fold, and pen). From the results of this study we suggest a hybrid design for artifact screening composed of both single artifact binary models as well as multiple instance models to optimize detection of each artifact.

The Application of Deep Learning for Lymph Node Segmentation: A Systematic Review

Automatic lymph node segmentation is the cornerstone for advances in computer vision tasks for early detection and staging of cancer. Traditional segmentation methods are constrained by manual delineation and variability in operator proficiency, limiting their ability to achieve high accuracy. The introduction of deep learning technologies offers new possibilities for improving the accuracy of lymph node image analysis. This study evaluates the application of deep learning in lymph node segmentation and discusses the methodologies of various deep learning architectures such as convolutional neural networks, encoder-decoder networks, and transformers in analyzing medical imaging data across different modalities. Despite the advancements, it still confronts challenges like the shape diversity of lymph nodes, the scarcity of accurately labeled datasets, and the inadequate development of methods that are robust and generalizable across different imaging modalities. To the best of our knowledge, this is the first study that provides a comprehensive overview of the application of deep learning techniques in lymph node segmentation task. Furthermore, this study also explores potential future research directions, including multimodal fusion techniques, transfer learning, and the use of large-scale pre-trained models to overcome current limitations while enhancing cancer diagnosis and treatment planning strategies.